From the Current Hotline

Tuesday, November 11, 2025

Halozyme Therapeutics ($70; HALO) said Johnson & Johnson ($194; JNJ) received FDA approval...


Read More...

Performance Update

Read More...

Our Quadrix® Stock-Rating System

Access our proprietary stock-rating system with rankings on more than 3,500 U.S. stocks, providing recommendations in specific categories we think are timely, and the details behind our ratings.

Read More...

Get our best stock ideas when you sign up for a FREE 30-day trial to Upside. You'll gain full access to the exclusive subscriber-only website where you can get stock recommendations, read the current issue, access the Quadrix® stock-rating system, and much more!